Viewing nowInnoen Abelton 150 mg Tablets (Irbesartan)
Irbesartan 150mg
Tablet · Prescription medication
HK Innoen Co., Ltd.

MFDS item code 200808562 · Notified 2008.08.08 · Insurance code 640005840
Treatment of essential hypertension and nephropathy in patients with type 2 diabetes and hypertension
This medication is used for the treatment of hypertension in patients with essential hypertension. It effectively protects kidney function in patients with type 2 diabetes who have accompanying kidney disease and assists in treatment. Therefore, it is a drug that contributes to stabilizing blood pressure and preventing kidney complications.
This medicine may be taken with or without food. Essential hypertension Adults: Administer irbesartan orally at 150 mg once daily. If the effect is insufficient, the dose may be increased to 300 mg. In general, blood pressure control over 24 hours is better with 150 mg once daily than with 75 mg once daily, but 75 mg may be considered in certain cases (e.g., at the start of treatment, in patients on hemodialysis, or in older adults aged 75 years and older). If blood pressure is not adequately controlled with monotherapy, another antihypertensive agent may be administered concomitantly. The effect is increased particularly when used with a low dose of a diuretic (e.g., hydrochlorothiazide). Nephropathy in patients with type 2 diabetes and hypertension Adults: It is recommended to start oral administration of this medicine at 150 mg once daily and increase the dose to 300 mg for maintenance. If necessary, another antihypertensive agent may be administered concomitantly to achieve the target blood pressure. Older adults Dose adjustment is generally not necessary, but an initial dose of 75 mg should be considered in older adults aged 75 years and older. Patients with renal impairment Dose adjustment is generally not necessary, but an initial dose of 75 mg should be considered in patients on hemodialysis. Patients with hepatic impairment Dose adjustment is generally not necessary in patients with mild to moderate hepatic impairment, but it is recommended not to exceed 150 mg per day. However, there is no clinical experience in patients with severe hepatic impairment.
This medication can cause serious harm to the fetus and newborn, especially during pregnancy, so it should be discontinued immediately if pregnancy is confirmed. It should not be used in pregnant or possibly pregnant women, nursing mothers, patients with severe liver impairment, and patients with certain genetic diseases. Cautious use is required for elderly patients and those with hyperkalemia, liver impairment, and heart and kidney disease, with regular monitoring of blood pressure, kidney function, and electrolyte levels. During treatment, side effects such as dizziness, fatigue, headache, indigestion, and rash may occur, and in rare cases, angioedema or severe allergic reactions may arise, requiring caution. Due to the blood pressure-lowering effects, symptoms such as hypotension, shock, and loss of consciousness may occur, requiring close observation of the patient's condition. Patients with kidney disease should be especially cautious due to the risk of worsening kidney function, and treatment should be stopped if liver function abnormalities occur. This medication can increase serum potassium levels, so it should be avoided in combination with potassium supplements or potassium-sparing diuretics, and potassium levels should be monitored regularly. When used with other antihypertensives, blood pressure reduction may be enhanced, and consultation with a healthcare provider is necessary before taking it. Patients may experience dizziness or fatigue when driving or operating machinery, requiring caution. Patients undergoing diabetes treatment or at risk of hypoglycemia should consult with a doctor and check their blood glucose levels before taking this medication. In case of overdose, symptoms such as hypotension, tachycardia, and bradycardia may occur, necessitating immediate medical assistance. It is safe to store this medication out of reach of children and not to transfer it to another container.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent air or moisture from entering, and kept in a cool, dry place below 30 degrees Celsius. This will help maintain the effectiveness of the medication for a longer time.
White or almost white, oval, biconvex film-coated tablets
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowIrbesartan 150mg
Tablet · Prescription medication
HK Innoen Co., Ltd.

Irbesartan 150mg
Tablet · Prescription medication
Handok Co., Ltd.

Irbesartan 300mg
Tablet · Prescription medication
Handok Co., Ltd.
Irbesartan 150mg
Tablet · Prescription medication
Hanwha Pharmaceutical Co., Ltd.

Irbesartan 150mg
Tablet · Prescription medication
Kips Biopharma Co., Ltd.

Irbesartan 150mg
Tablet · Prescription medication
Anguk Pharmaceutical Co., Ltd.
Irbesartan 150mg
Prescription medication
Bionex Co., Ltd.

Irbesartan 150mg
Tablet · Prescription medication
KMS Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.